External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

Hawaiian Eye 2025

-
Coming soon
07:37 PM
Duration 6mins United States
Real-World Clinical Outcomes Update in Patients With Neovascular Age-Related Macular Degeneration in the US: The FARETINA-AMD Study
Ali F, Bonine N, Ko S, Zwick E, Shaia J, Borkar D, Singh R

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
07:49 PM
Duration 6mins United States
Clinical Impact of the Port Delivery System With Ranibizumab (PDS) in Retinal Diseases
Graff J, Campochiaro P, Chakravarthy U, Emanuelli A, Gill M, Rachitskaya A, Wirthlin R, Gune S, Blotner S, Singh N

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
08:07 PM
Duration 6mins United States
Faricimab▼ for Polypoidal Choroidal Vasculopathy: Initial Results from the Phase 3b/4 SALWEEN Trial
Chhablani J, Lee WK, Lai T, Iida T, Chen SJ, Cheung G, Bai R, Margaron P, Duc AN, Koh A

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
07:37 PM
Duration 6mins United States
Impact of Early Intraretinal Fluid Reduction on 1-Year Outcomes in DME
Talcott KE, Sadda S, Lim JI, Wang Y, Hibar D, Maunz A, Lu Huanxiang, Albrecht T, Amador M, Gibson K, Litts KM

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
07:49 PM
Duration 6mins United States
Real-World Clinical Outcomes Update in Patients With Diabetic Macular Edema Treated With Faricimab▼ in the US: The FARETINA-DME Study
Borkar D, Bonine N, Leng T, Ko S, Shaia J, Zwick E, Ali F, Singh R

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
07:55 PM
Duration 6mins United States
Four-Year Outcomes of Faricimab▼ in DME: First Time Safety and Efficacy Results From The RHONE-X Long-Term Extension Trial
London N, Sim D, Abreu F, Khanani A, Kotak A, Lai T, Schlottmann S, Thommen J, Tang Y, Kotecha A

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
08:07 PM
Duration 6mins United States
Efficacy and Safety of Faricimab▼ in Underrepresented Patients with DME: Top-line Results From the Phase 4 ELEVATUM Study
Brown J, Amador M, Cunningham M, Coney J, Emanuelli A, Huddleston S, Scott A, Milunovich S, Yang M, Lu X-Y, Gonzalez L

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar